{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:35:02Z","timestamp":1793900102001,"version":"4.8.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital Health Development Research Special Project","award":["2024-1-4053"],"award-info":[{"award-number":["2024-1-4053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-025-01546-z","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:33:55Z","timestamp":1748255635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of denosumab in lipid metabolism disorders: clinical significance and potential mechanisms"],"prefix":"10.1007","volume":"20","author":[{"given":"Yuan","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"1546_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A (2021) Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell 81:3708\u20133730. https:\/\/doi.org\/10.1016\/j.molcel.2021.08.027","journal-title":"Mol Cell"},{"key":"1546_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2018.09.010","volume":"487","author":"M Castro Cabezas","year":"2018","unstructured":"Castro Cabezas M, Burggraaf B, Klop B (2018) Dyslipidemias in clinical practice. Clin Chim Acta 487:117\u2013125. https:\/\/doi.org\/10.1016\/j.cca.2018.09.010","journal-title":"Clin Chim Acta"},{"key":"1546_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the global burden of disease study 2013. Lancet 384:766\u2013781. https:\/\/doi.org\/10.1016\/S0140-6736(14)60460-8","journal-title":"Lancet"},{"key":"1546_CR4","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397:2212\u20132224. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3","journal-title":"Lancet"},{"key":"1546_CR5","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-17-0920","volume":"178","author":"E Canalis","year":"2018","unstructured":"Canalis E (2018) Novel anabolic treatments for osteoporosis. Eur J Endocrinol 178:R33\u2013R44. https:\/\/doi.org\/10.1530\/EJE-17-0920","journal-title":"Eur J Endocrinol"},{"key":"1546_CR6","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1001\/jama.286.22.2865","volume":"286","author":"CH Chesnut Iii","year":"2001","unstructured":"Chesnut Iii CH (2001) Osteoporosis, an underdiagnosed disease. JAMA 286:2865. https:\/\/doi.org\/10.1001\/jama.286.22.2865","journal-title":"JAMA"},{"key":"1546_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","volume":"194","author":"NE Lane","year":"2006","unstructured":"Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3\u2013S11. https:\/\/doi.org\/10.1016\/j.ajog.2005.08.047","journal-title":"Am J Obstet Gynecol"},{"key":"1546_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","volume":"10","author":"T Vilaca","year":"2022","unstructured":"Vilaca T, Eastell R, Schini M (2022) Osteoporosis in men. Lancet Diabetes Endocrinol 10:273\u2013283. https:\/\/doi.org\/10.1016\/S2213-8587(22)00012-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1546_CR9","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.gendis.2023.101122","volume":"11","author":"J Zhang","year":"2024","unstructured":"Zhang J, Hu W, Zou Z et al (2024) The role of lipid metabolism in osteoporosis: clinical implication and cellular mechanism. Genes & Diseases 11:101122. https:\/\/doi.org\/10.1016\/j.gendis.2023.101122","journal-title":"Genes & Diseases"},{"key":"1546_CR10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1210\/jc.2006-0572","volume":"92","author":"L-J Zhao","year":"2007","unstructured":"Zhao L-J, Liu Y-J, Liu P-Y et al (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640\u20131646. https:\/\/doi.org\/10.1210\/jc.2006-0572","journal-title":"J Clin Endocrinol Metab"},{"key":"1546_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12944-021-01615-5","volume":"21","author":"B Wang","year":"2022","unstructured":"Wang B, Wang H, Li Y, Song L (2022) Lipid metabolism within the bone micro-environment is closely associated with bone metabolism in physiological and pathophysiological stages. Lipids Health Dis 21:5. https:\/\/doi.org\/10.1186\/s12944-021-01615-5","journal-title":"Lipids Health Dis"},{"key":"1546_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s11892-014-0556-3","volume":"14","author":"SL Booth","year":"2014","unstructured":"Booth SL, Centi AJ, Gundberg C (2014) Bone as an endocrine organ relevant to diabetes. Curr Diab Rep 14:556. https:\/\/doi.org\/10.1007\/s11892-014-0556-3","journal-title":"Curr Diab Rep"},{"key":"1546_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/967673","volume":"2015","author":"J Shao","year":"2015","unstructured":"Shao J, Wang Z, Yang T et al (2015) Bone regulates glucose metabolism as an endocrine organ through osteocalcin. International Journal of Endocrinology 2015:1\u20139. https:\/\/doi.org\/10.1155\/2015\/967673","journal-title":"International Journal of Endocrinology"},{"key":"1546_CR14","doi-asserted-by":"publisher","first-page":"687037","DOI":"10.3389\/fimmu.2021.687037","volume":"12","author":"Y Saxena","year":"2021","unstructured":"Saxena Y, Routh S, Mukhopadhaya A (2021) Immunoporosis: role of innate immune cells in osteoporosis. Front Immunol 12:687037. https:\/\/doi.org\/10.3389\/fimmu.2021.687037","journal-title":"Front Immunol"},{"key":"1546_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55:31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013","journal-title":"Immunity"},{"key":"1546_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139\u2013146. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018","journal-title":"Arch Biochem Biophys"},{"key":"1546_CR17","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2165","volume":"9","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9:S1. https:\/\/doi.org\/10.1186\/ar2165","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1546_CR18","first-page":"372","volume":"20","author":"K Gkastaris","year":"2020","unstructured":"Gkastaris K, Goulis DG, Potoupnis M et al (2020) Obesity, osteoporosis and bone metabolism. J Musculoskelet Neuronal Interact 20(3):372\u2013381","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1546_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13679-023-00505-4","volume":"12","author":"ID Vachliotis","year":"2023","unstructured":"Vachliotis ID, Polyzos SA (2023) Osteoprotegerin\/receptor activator of nuclear factor-kappa B ligand\/receptor activator of nuclear factor-kappa B axis in obesity, type 2 diabetes mellitus, and nonalcoholic fatty liver disease. Curr Obes Rep 12:147\u2013162. https:\/\/doi.org\/10.1007\/s13679-023-00505-4","journal-title":"Curr Obes Rep"},{"key":"1546_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765. https:\/\/doi.org\/10.1056\/NEJMoa0809493","journal-title":"N Engl J Med"},{"key":"1546_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS et al (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11:401\u2013419. https:\/\/doi.org\/10.1038\/nrd3705","journal-title":"Nat Rev Drug Discov"},{"key":"1546_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10741-021-10153-2","volume":"27","author":"M Dutka","year":"2022","unstructured":"Dutka M, Bobi\u0144ski R, Wojakowski W et al (2022) Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases. Heart Fail Rev 27:1395\u20131411. https:\/\/doi.org\/10.1007\/s10741-021-10153-2","journal-title":"Heart Fail Rev"},{"key":"1546_CR23","doi-asserted-by":"publisher","first-page":"e2354734","DOI":"10.1001\/jamanetworkopen.2023.54734","volume":"7","author":"H-K Huang","year":"2024","unstructured":"Huang H-K, Chuang AT-M, Liao T-C et al (2024) Denosumab and the risk of diabetes in patients treated for osteoporosis. JAMA Netw Open 7:e2354734. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54734","journal-title":"JAMA Netw Open"},{"key":"1546_CR24","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1210\/jc.2010-2784","volume":"96","author":"S Boonen","year":"2011","unstructured":"Boonen S, Adachi JD, Man Z et al (2011) Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocr Metab 96:1727\u20131736. https:\/\/doi.org\/10.1210\/jc.2010-2784","journal-title":"J Clin Endocr Metab"},{"key":"1546_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/er.2017-00111","volume":"38","author":"MW Schwartz","year":"2017","unstructured":"Schwartz MW, Seeley RJ, Zeltser LM et al (2017) Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev 38:267\u2013296. https:\/\/doi.org\/10.1210\/er.2017-00111","journal-title":"Endocr Rev"},{"key":"1546_CR26","doi-asserted-by":"publisher","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2017) Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol 42:. https:\/\/doi.org\/10.23736\/S0391-1977.16.02563-3","DOI":"10.23736\/S0391-1977.16.02563-3"},{"key":"1546_CR27","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/jbmr.1865","volume":"28","author":"AV Schwartz","year":"2013","unstructured":"Schwartz AV, Schafer AL, Grey A et al (2013) Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res 28:1348\u20131354. https:\/\/doi.org\/10.1002\/jbmr.1865","journal-title":"J Bone Miner Res"},{"key":"1546_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/21556660.2021.1989194","volume":"10","author":"BT Pacheco-Soto","year":"2021","unstructured":"Pacheco-Soto BT, Elguezabal-Rodelo RG, Porchia LM et al (2021) Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis. Journal of Drug Assessment 10:97\u2013105. https:\/\/doi.org\/10.1080\/21556660.2021.1989194","journal-title":"Journal of Drug Assessment"},{"key":"1546_CR29","doi-asserted-by":"publisher","first-page":"E866","DOI":"10.1152\/ajpendo.00397.2019","volume":"318","author":"FS Matsuo","year":"2020","unstructured":"Matsuo FS, Cavalcanti de Ara\u00fajo PH, Mota RF et al (2020) RANKL induces beige adipocyte differentiation in preadipocytes. Am J Physiol Endocrinol Metab 318:E866\u2013E877. https:\/\/doi.org\/10.1152\/ajpendo.00397.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1546_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7740079","volume":"2022","author":"RF Mota","year":"2022","unstructured":"Mota RF, Cavalcanti De Ara\u00fajo PH, Cezine MER et al (2022) RANKL impairs the TLR4 pathway by increasing TRAF6 and RANK interaction in macrophages. Biomed Res Int 2022:1\u201313. https:\/\/doi.org\/10.1155\/2022\/7740079","journal-title":"Biomed Res Int"},{"key":"1546_CR31","doi-asserted-by":"publisher","unstructured":"Byrne CD, Targher G (2015) NAFLD: a multisystem disease. JOURNAL OF HEPATOLOGY 62(1 Suppl):S47\u201364.\u00a0https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"1546_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12902-016-0148-0","volume":"16","author":"A Takeno","year":"2016","unstructured":"Takeno A, Yamamoto M, Notsu M, Sugimoto T (2016) Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: A case report. BMC Endocr Disord 16:66. https:\/\/doi.org\/10.1186\/s12902-016-0148-0","journal-title":"BMC Endocr Disord"},{"key":"1546_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/352858","volume":"2015","author":"E Passeri","year":"2015","unstructured":"Passeri E, Benedini S, Costa E, Corbetta S (2015) A single 60 mg dose of denosumab might improve hepatic insulin sensitivity in postmenopausal nondiabetic severe osteoporotic women. International Journal of Endocrinology 2015:1\u20135. https:\/\/doi.org\/10.1155\/2015\/352858","journal-title":"International Journal of Endocrinology"},{"key":"1546_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018067","volume":"98","author":"I Abe","year":"2019","unstructured":"Abe I, Ochi K, Takashi Y et al (2019) Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters. Medicine (Baltimore) 98:e18067. https:\/\/doi.org\/10.1097\/MD.0000000000018067","journal-title":"Medicine (Baltimore)"},{"key":"1546_CR35","doi-asserted-by":"publisher","first-page":"110379","DOI":"10.1016\/j.mehy.2020.110379","volume":"146","author":"A Ps","year":"2020","unstructured":"Ps A, Antonis G (2020) Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: a hypothesis on drug repurposing. Med Hypotheses 146:110379. https:\/\/doi.org\/10.1016\/j.mehy.2020.110379","journal-title":"Med Hypotheses"},{"key":"1546_CR36","doi-asserted-by":"publisher","first-page":"e1857","DOI":"10.1210\/clinem\/dgae003","volume":"109","author":"SK Ramchand","year":"2024","unstructured":"Ramchand SK, Hoermann R, White S et al (2024) Cardiometabolic effects of denosumab in premenopausal women with breast cancer receiving estradiol suppression: RCT. J Clin Endocrinol Metab 109:e1857\u2013e1866. https:\/\/doi.org\/10.1210\/clinem\/dgae003","journal-title":"J Clin Endocrinol Metab"},{"key":"1546_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6953421","volume":"2020","author":"L Zhong","year":"2020","unstructured":"Zhong L, Yuan J, Huang L et al (2020) RANKL is involved in Runx2-triggered hepatic infiltration of macrophages in mice with NAFLD induced by a high-fat diet. Biomed Res Int 2020:1\u20138. https:\/\/doi.org\/10.1155\/2020\/6953421","journal-title":"Biomed Res Int"},{"key":"1546_CR38","doi-asserted-by":"publisher","first-page":"10289","DOI":"10.3390\/ijms241210289","volume":"24","author":"S-C Lin","year":"2023","unstructured":"Lin S-C, Tsou S-H, Kuo C-Y et al (2023) Denosumab attenuates glucolipotoxicity-induced \u03b2-cell dysfunction and apoptosis by attenuating RANK\/RANKL signals. IJMS 24:10289. https:\/\/doi.org\/10.3390\/ijms241210289","journal-title":"IJMS"},{"key":"1546_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P (2021) The changing landscape of atherosclerosis. Nature 592:524\u2013533. https:\/\/doi.org\/10.1038\/s41586-021-03392-8","journal-title":"Nature"},{"key":"1546_CR40","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47:C7\u2013C12. https:\/\/doi.org\/10.1016\/j.jacc.2005.09.068","journal-title":"J Am Coll Cardiol"},{"key":"1546_CR41","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","volume":"95","author":"P Collin-Osdoby","year":"2004","unstructured":"Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95:1046\u20131057. https:\/\/doi.org\/10.1161\/01.RES.0000149165.99974.12","journal-title":"Circ Res"},{"key":"1546_CR42","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00125-014-3348-z","volume":"57","author":"A Ndip","year":"2014","unstructured":"Ndip A, Wilkinson FL, Jude EB et al (2014) RANKL\u2013OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy. Diabetologia 57:2251\u20132260. https:\/\/doi.org\/10.1007\/s00125-014-3348-z","journal-title":"Diabetologia"},{"key":"1546_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2009.07.001","volume":"15","author":"V Persy","year":"2009","unstructured":"Persy V, D\u2019Haese P (2009) Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15:405\u2013416. https:\/\/doi.org\/10.1016\/j.molmed.2009.07.001","journal-title":"Trends Mol Med"},{"key":"1546_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/1756-185X.12842","volume":"20","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Feng B (2017) Systematic review and meta-analysis for the association of bone mineral density and osteoporosis\/osteopenia with vascular calcification in women. Int J Rheum Dis 20:154\u2013160. https:\/\/doi.org\/10.1111\/1756-185X.12842","journal-title":"Int J Rheum Dis"},{"key":"1546_CR45","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/07853890.2012.727019","volume":"45","author":"M Montagnana","year":"2013","unstructured":"Montagnana M, Lippi G, Danese E, Guidi GC (2013) The role of osteoprotegerin in cardiovascular disease. Ann Med 45:254\u2013264. https:\/\/doi.org\/10.3109\/07853890.2012.727019","journal-title":"Ann Med"},{"key":"1546_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1752854","volume":"2016","author":"S Bernardi","year":"2016","unstructured":"Bernardi S, Bossi F, Toffoli B, Fabris B (2016) Roles and clinical applications of OPG and TRAIL as biomarkers in cardiovascular disease. Biomed Res Int 2016:1\u201312. https:\/\/doi.org\/10.1155\/2016\/1752854","journal-title":"Biomed Res Int"},{"key":"1546_CR47","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.jacc.2005.12.054","volume":"47","author":"DV Anand","year":"2006","unstructured":"Anand DV, Lahiri A, Lim E et al (2006) The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol 47:1850\u20131857. https:\/\/doi.org\/10.1016\/j.jacc.2005.12.054","journal-title":"J Am Coll Cardiol"},{"key":"1546_CR48","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/2193-1801-2-658","volume":"2","author":"M Bjerre","year":"2013","unstructured":"Bjerre M (2013) Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications. Springerplus 2:658. https:\/\/doi.org\/10.1186\/2193-1801-2-658","journal-title":"Springerplus"},{"key":"1546_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbmr.4157","volume":"36","author":"AH Seeto","year":"2020","unstructured":"Seeto AH, Abrahamsen B, Ebeling PR, Rodr\u00edguez AJ (2020) Cardiovascular safety of denosumab across multiple indications: a systematic review and meta-analysis of randomized trials. J Bone Miner Res 36:24\u201340. https:\/\/doi.org\/10.1002\/jbmr.4157","journal-title":"J Bone Miner Res"},{"key":"1546_CR50","doi-asserted-by":"publisher","first-page":"e084516","DOI":"10.1136\/bmjopen-2024-084516","volume":"14","author":"SL Saunders","year":"2024","unstructured":"Saunders SL, Chaudhri K, McOrist NS et al (2024) Do bisphosphonates and RANKL inhibitors alter the progression of coronary artery calcification? A systematic review BMJ Open 14:e084516. https:\/\/doi.org\/10.1136\/bmjopen-2024-084516","journal-title":"A systematic review BMJ Open"},{"key":"1546_CR51","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00198-020-05391-3","volume":"31","author":"C-L Chen","year":"2020","unstructured":"Chen C-L, Chen N-C, Wu F-Z, Wu M-T (2020) Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study. Osteoporos Int 31:1507\u20131516. https:\/\/doi.org\/10.1007\/s00198-020-05391-3","journal-title":"Osteoporos Int"},{"key":"1546_CR52","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","volume":"143","author":"TA Pawade","year":"2021","unstructured":"Pawade TA, Doris MK, Bing R et al (2021) Effect of denosumab or alendronic acid on the progression of aortic stenosis. Circulation 143:2418\u20132427. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053708","journal-title":"Circulation"},{"key":"1546_CR53","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s40265-020-01364-2","volume":"80","author":"NR Fuggle","year":"2020","unstructured":"Fuggle NR, Cooper C, Harvey NC et al (2020) Assessment of cardiovascular safety of anti-osteoporosis drugs. Drugs 80:1537\u20131552. https:\/\/doi.org\/10.1007\/s40265-020-01364-2","journal-title":"Drugs"},{"key":"1546_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/ATVBAHA.118.311874","volume":"39","author":"G-L Lee","year":"2019","unstructured":"Lee G-L, Yeh C-C, Wu J-Y et al (2019) TLR2 promotes vascular smooth muscle cell chondrogenic differentiation and consequent calcification via the concerted actions of osteoprotegerin suppression and IL-6\u2013mediated RANKL induction. Arterioscler Thromb Vasc Biol 39:432\u2013445. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311874","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1546_CR55","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3349\/ymj.2007.48.5.765","volume":"48","author":"J-J An","year":"2007","unstructured":"An J-J, Han D-H, Kim D-M et al (2007) Expression and regulation of osteoprotegerin in adipose tissue. Yonsei Med J 48:765\u2013772. https:\/\/doi.org\/10.3349\/ymj.2007.48.5.765","journal-title":"Yonsei Med J"},{"key":"1546_CR56","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2337\/db18-1055","volume":"68","author":"C Zhang","year":"2019","unstructured":"Zhang C, Luo X, Chen J et al (2019) Osteoprotegerin promotes liver steatosis by targeting the ERK\u2013PPAR-\u03b3\u2013CD36 pathway. Diabetes 68:1902\u20131914. https:\/\/doi.org\/10.2337\/db18-1055","journal-title":"Diabetes"},{"key":"1546_CR57","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cells8080784","volume":"8","author":"X Fu","year":"2019","unstructured":"Fu X, Liu G, Halim A et al (2019) Mesenchymal stem cell migration and tissue repair. Cells 8:784. https:\/\/doi.org\/10.3390\/cells8080784","journal-title":"Cells"},{"key":"1546_CR58","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ijms19020360","volume":"19","author":"L Hu","year":"2018","unstructured":"Hu L, Yin C, Zhao F et al (2018) Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int J Mol Sci 19:360. https:\/\/doi.org\/10.3390\/ijms19020360","journal-title":"Int J Mol Sci"},{"key":"1546_CR59","doi-asserted-by":"publisher","first-page":"101545","DOI":"10.1016\/j.beem.2021.101545","volume":"35","author":"M Tencerova","year":"2021","unstructured":"Tencerova M, Ferencakova M, Kassem M (2021) Bone marrow adipose tissue: role in bone remodeling and energy metabolism. Best Pract Res Clin Endocrinol Metab 35:101545. https:\/\/doi.org\/10.1016\/j.beem.2021.101545","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1546_CR60","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4248\/BR201301005","volume":"1","author":"FJA De Paula","year":"2013","unstructured":"De Paula FJA, Rosen CJ (2013) Bone remodeling and energy metabolism: new perspectives. Bone Res 1:72\u201384. https:\/\/doi.org\/10.4248\/BR201301005","journal-title":"Bone Res"},{"key":"1546_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11914-018-0425-0","volume":"16","author":"J Cornish","year":"2018","unstructured":"Cornish J, Wang T, Lin J (2018) Role of marrow adipocytes in regulation of energy metabolism and bone homeostasis. Curr Osteoporos Rep 16:116\u2013122. https:\/\/doi.org\/10.1007\/s11914-018-0425-0","journal-title":"Curr Osteoporos Rep"},{"key":"1546_CR62","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/mmr.2015.3472","volume":"12","author":"L Tian","year":"2015","unstructured":"Tian L, Yu X (2015) Lipid metabolism disorders and bone dysfunction-interrelated and mutually regulated (review). Mol Med Rep 12:783\u2013794. https:\/\/doi.org\/10.3892\/mmr.2015.3472","journal-title":"Mol Med Rep"},{"key":"1546_CR63","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1038\/s41467-020-16878-2","volume":"11","author":"KJ Suchacki","year":"2020","unstructured":"Suchacki KJ, Tavares AAS, Mattiucci D et al (2020) Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis. Nat Commun 11:3097. https:\/\/doi.org\/10.1038\/s41467-020-16878-2","journal-title":"Nat Commun"},{"key":"1546_CR64","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cyto.2011.09.005","volume":"56","author":"H Goto","year":"2011","unstructured":"Goto H, Hozumi A, Osaki M et al (2011) Primary human bone marrow adipocytes support TNF-\u03b1-induced osteoclast differentiation and function through RANKL expression. Cytokine 56:662\u2013668. https:\/\/doi.org\/10.1016\/j.cyto.2011.09.005","journal-title":"Cytokine"},{"key":"1546_CR65","doi-asserted-by":"publisher","unstructured":"Hu Y, Li X, Zhi X, et al (2021) RANKL from bone marrow adipose lineage cells promotes osteoclast formation and bone loss. EMBO reports 22:e52481. https:\/\/doi.org\/10.15252\/embr.202152481","DOI":"10.15252\/embr.202152481"},{"key":"1546_CR66","doi-asserted-by":"publisher","first-page":"e140214","DOI":"10.1172\/JCI140214","volume":"131","author":"W Yu","year":"2021","unstructured":"Yu W, Zhong L, Yao L et al (2021) Bone marrow adipogenic lineage precursors (MALPs) promote osteoclastogenesis in bone remodeling and pathologic bone loss. J Clin Invest 131:e140214. https:\/\/doi.org\/10.1172\/JCI140214","journal-title":"J Clin Invest"},{"key":"1546_CR67","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","volume":"25","author":"Y Fan","year":"2017","unstructured":"Fan Y, Hanai J, Le PT et al (2017) Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell Metab 25:661\u2013672. https:\/\/doi.org\/10.1016\/j.cmet.2017.01.001","journal-title":"Cell Metab"},{"key":"1546_CR68","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/jbmr.2112","volume":"29","author":"V Rinotas","year":"2014","unstructured":"Rinotas V, Niti A, Dacquin R et al (2014) Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice. J Bone Miner Res 29:1158\u20131169. https:\/\/doi.org\/10.1002\/jbmr.2112","journal-title":"J Bone Miner Res"},{"key":"1546_CR69","doi-asserted-by":"publisher","first-page":"1442046","DOI":"10.3389\/fendo.2024.1442046","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Zuo X, Lu L et al (2024) Vertebral marrow fat fraction is associated with circulating RANKL in postmenopausal females. Front Endocrinol 15:1442046. https:\/\/doi.org\/10.3389\/fendo.2024.1442046","journal-title":"Front Endocrinol"},{"key":"1546_CR70","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jss.2012.03.018","volume":"180","author":"J Jin","year":"2013","unstructured":"Jin J, Wang L, Wang X et al (2013) Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL\/OPG ratio to impair osteoclast differentiation. J Surg Res 180:e21\u2013e29. https:\/\/doi.org\/10.1016\/j.jss.2012.03.018","journal-title":"J Surg Res"},{"key":"1546_CR71","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki M, Takayanagi H (2019) Osteoimmunology: evolving concepts in bone\u2013immune interactions in health and disease. Nat Rev Immunol 19:626\u2013642. https:\/\/doi.org\/10.1038\/s41577-019-0178-8","journal-title":"Nat Rev Immunol"},{"key":"1546_CR72","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00125-007-0672-6","volume":"50","author":"J Schrader","year":"2007","unstructured":"Schrader J, Rennekamp W, Niebergall U et al (2007) Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death. Diabetologia 50:1243\u20131247. https:\/\/doi.org\/10.1007\/s00125-007-0672-6","journal-title":"Diabetologia"},{"key":"1546_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2014.06.004","volume":"394","author":"S Bernardi","year":"2014","unstructured":"Bernardi S, Fabris B, Thomas M et al (2014) Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes. Mol Cell Endocrinol 394:13\u201320. https:\/\/doi.org\/10.1016\/j.mce.2014.06.004","journal-title":"Mol Cell Endocrinol"},{"key":"1546_CR74","doi-asserted-by":"publisher","unstructured":"Lin H, Liu T, Li X, et al (2020) The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease. Annals of Translational Medicine 8:1009\u20131009. https:\/\/doi.org\/10.21037\/atm-20-5307","DOI":"10.21037\/atm-20-5307"},{"key":"1546_CR75","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11914-017-0382-z","volume":"15","author":"J Yan","year":"2017","unstructured":"Yan J, Charles JF (2017) Gut microbiome and bone: to build, destroy, or both? Curr Osteoporos Rep 15:376\u2013384. https:\/\/doi.org\/10.1007\/s11914-017-0382-z","journal-title":"Curr Osteoporos Rep"},{"key":"1546_CR76","doi-asserted-by":"publisher","first-page":"e00810","DOI":"10.1002\/mbo3.810","volume":"8","author":"L Li","year":"2019","unstructured":"Li L, Rao S, Cheng Y et al (2019) Microbial osteoporosis: the interplay between the gut microbiota and bones via host metabolism and immunity. MicrobiologyOpen 8:e00810. https:\/\/doi.org\/10.1002\/mbo3.810","journal-title":"MicrobiologyOpen"},{"key":"1546_CR77","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16:461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1546_CR78","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.archoralbio.2008.02.016","volume":"53","author":"T Katono","year":"2008","unstructured":"Katono T, Kawato T, Tanabe N et al (2008) Sodium butyrate stimulates mineralized nodule formation and osteoprotegerin expression by human osteoblasts. Arch Oral Biol 53:903\u2013909. https:\/\/doi.org\/10.1016\/j.archoralbio.2008.02.016","journal-title":"Arch Oral Biol"},{"key":"1546_CR79","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu M, Pautz S, Kohl V et al (2019) The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun 10:760. https:\/\/doi.org\/10.1038\/s41467-019-08711-2","journal-title":"Nat Commun"},{"key":"1546_CR80","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450. https:\/\/doi.org\/10.1038\/nature12721","journal-title":"Nature"},{"key":"1546_CR81","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature10763","volume":"481","author":"G Karsenty","year":"2012","unstructured":"Karsenty G, Ferron M (2012) The contribution of bone to whole-organism physiology. Nature 481:314\u2013320. https:\/\/doi.org\/10.1038\/nature10763","journal-title":"Nature"},{"key":"1546_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40779-024-00540-9","volume":"11","author":"A-F Deng","year":"2024","unstructured":"Deng A-F, Wang F-X, Wang S-C et al (2024) Bone-organ axes: bidirectional crosstalk. Mil Med Res 11:37. https:\/\/doi.org\/10.1186\/s40779-024-00540-9","journal-title":"Mil Med Res"},{"key":"1546_CR83","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","volume":"142","author":"M Ferron","year":"2010","unstructured":"Ferron M, Wei J, Yoshizawa T et al (2010) Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296\u2013308. https:\/\/doi.org\/10.1016\/j.cell.2010.06.003","journal-title":"Cell"},{"key":"1546_CR84","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456\u2013469. https:\/\/doi.org\/10.1016\/j.cell.2007.05.047","journal-title":"Cell"},{"key":"1546_CR85","doi-asserted-by":"publisher","unstructured":"Yang Z, Li P, Shang Q, et al (2020) CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPAR\u03b1 expression. SCIENCE ADVANCES 6(48):eabc5022. https:\/\/doi.org\/10.1126\/sciadv.abc5022","DOI":"10.1126\/sciadv.abc5022"},{"key":"1546_CR86","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jot.2024.07.008","volume":"48","author":"H Gao","year":"2024","unstructured":"Gao H, Peng X, Li N et al (2024) Emerging role of liver-bone axis in osteoporosis. J Orthop Translat 48:217\u2013231. https:\/\/doi.org\/10.1016\/j.jot.2024.07.008","journal-title":"J Orthop Translat"},{"key":"1546_CR87","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1002\/jcp.30414","volume":"236","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang C, Wang J et al (2021) Bone-adipose tissue crosstalk: role of adipose tissue derived extracellular vesicles in bone diseases. Journal Cellular Physiology 236:7874\u20137886. https:\/\/doi.org\/10.1002\/jcp.30414","journal-title":"Journal Cellular Physiology"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01546-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01546-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01546-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:17:26Z","timestamp":1766524646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01546-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1546"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01546-z","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"68"}}